ICU sedation, delirium & recovery
Long-term survival after intensive care for COVID-19: a nationwide cohort study of more than 8000 patients
Main finding · 360-day mortalityResult — go to the resultOdds ratio 1.33 95% CI 1.17–1.52Authors' conclusion
This study confirms the increased severity of disease in critically ill men with COVID-19, even in a long-term perspective. However, mortality beyond 90 days was strikingly low, indicating high probability of survival after the acute phase of illness.
Study context
- Population
- All adult COVID-19 patients admitted to Swedish ICUs until August 12, 20227,390 with complete 360-day data
- Participants
- 8,392 patients
- Exposure
- Men vs women
- Outcome
- Mortality after ICU admission
- Follow-up
- 360 days
Main finding
360-day mortality
Odds ratio
1.33
95% CI 1.17–1.52
By group
Men vs Women
OR 1.33 (95% CI 1.17–1.52)
As reported in the abstract
- Overall 360-day mortality
- 2206 (29.8%)
Observational data: associations, not effects.
Further findings
Overall mortality · 30 days
- Died within 30 days
- 1775 (24.4%)
Overall mortality · 90 days
- Died within 90 days
- 2125 (28.8%)
Other variables associated with 360-day mortality
- Age, cardiac disease, COPD/asthma, diabetes, immune deficiency, CKD, neuromuscular disease, malignancy associated with poor 360-day mortality
Original publication
Long-term survival after intensive care for COVID-19: a nationwide cohort study of more than 8000 patients. Ann Intensive Care. Published 29 August 2023. doi:10.
Composed by AI from the published abstract and checked against it. How Briefs are made →